Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti-RSV fusion (F) protein monoclonal antibody (mAb). While anti-F protein mAbs neutralize RSV, they are unable to pre...

Full description

Bibliographic Details
Main Authors:	Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, Ana M. Nuñez Castrejon, Rebecca M. DuBois, Larry J. Anderson, Lawrence M. Kauvar, Ralph A. Tripp
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Viruses
Subjects:	RSV G protein F protein mAb 3D3 2D10
Online Access:	https://www.mdpi.com/1999-4915/15/5/1067

Similar Items

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
by: Harrison C. Bergeron, et al.
Published: (2023-06-01)

Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
by: Harrison C. Bergeron, et al.
Published: (2021-02-01)

Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
by: Morgan D. McSweeney, et al.
Published: (2024-03-01)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge
by: Thomas J. Powell, et al.
Published: (2022-12-01)

Immunopathology of RSV: An Updated Review
by: Harrison C. Bergeron, et al.
Published: (2021-12-01)

Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
by: Sara A. Taleb, et al.
Published: (2021-08-01)

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
by: Abhijeet A. Bakre, et al.
Published: (2017-07-01)

Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease
by: Patricia A. Jorquera, et al.
Published: (2015-10-01)

Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin
by: Peter Mastrangelo, et al.
Published: (2021-02-01)

New Look at RSV Infection: Tissue Clearing and 3D Imaging of the Entire Mouse Lung at Cellular Resolution
by: Maxence Frétaud, et al.
Published: (2021-01-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
by: Ralph A. Tripp, et al.
Published: (2022-03-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01)

Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01)

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection
by: Nao Jounai, et al.
Published: (2017-02-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection
by: MengJie Hu, et al.
Published: (2023-05-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
by: Ilona Hagelstein, et al.
Published: (2021-04-01)

Employing QbD strategies to assess the impact of cell viability and density on the primary recovery of monoclonal antibodies
by: Ole Jacob Wohlenberg, et al.
Published: (2023-02-01)

Implementation of QbD strategies in the inoculum expansion of a mAb production process
by: Ole Jacob Böhl, et al.
Published: (2021-03-01)

Characterisation of RSV Fusion Proteins from South African Patients with RSV Disease, 2019 to 2020
by: Prince Mabilo, et al.
Published: (2022-10-01)

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor
by: Lars Radke, et al.
Published: (2017-08-01)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
by: Patricia A. Jorquera, et al.
Published: (2016-12-01)

Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)—Specific Monoclonal Antibodies
by: Lotte Jacobs, et al.
Published: (2023-09-01)

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina
by: Suada Heljic, et al.
Published: (2016-02-01)

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
by: Brian M. Maas, et al.
Published: (2021-11-01)

Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery
by: Kelly Schwinghamer, et al.
Published: (2023-10-01)

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
by: Katherine M. Eichinger, et al.
Published: (2017-10-01)

A three-dimensional A549 cell culture model to study respiratory syncytial virus infections
by: Fatima Saleh, et al.
Published: (2020-08-01)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
by: Jeehyun Lee, et al.
Published: (2022-01-01)

Development of an enzyme-linked immunosorbent assay based on viral antigen capture by anti-spike glycoprotein monoclonal antibody for detecting immunoglobulin A antibodies against porcine epidemic diarrhea virus in milk
by: Rui Li, et al.
Published: (2023-02-01)

Heavy chain dimers stabilized by disulfide bonds are required to promote in vitro assembly of trastuzumab
by: Mercè Farràs, et al.
Published: (2020-01-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
by: O'Hagan S, et al.
Published: (2023-09-01)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
by: Shibo Jiang, et al.
Published: (2013-01-01)

Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia
by: Hessa A. Al-Sharif, et al.
Published: (2020-11-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)